Abemaciclib 100mg tablets
NHS hospitals in England used £98,457,988 of indicative cost of Abemaciclib 100mg tablets in the 12 months to July 2026, about 0.4% of all hospital medicines spend. That is down 2.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Abemaciclib 100mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Abemaciclib 100mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £6,751,075 |
| The Royal Marsden Nhs Foundation Trust | £3,595,734 |
| The Clatterbridge Cancer Centre Nhs Ft | £3,090,915 |
| Univ Hpl B/Ham Nhs Foundation Trust | £2,952,950 |
| Nottingham University Hospitals Trust | £2,825,363 |
| Sheffield Teaching Hospitals Nhs Trust | £2,708,100 |
| Royal Free London Nhs Foundation Trust | £2,429,325 |
| Royal Surrey County Hosp Nhs Found Trust | £2,205,863 |
| Derby Teaching Hospitals Nhs Found Trust | £2,129,795 |
| East And North Hertfordshire Nhs Trust | £1,976,500 |
The primary-care picture
Abemaciclib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Abemaciclib medicine page.